PTC THERAPEUTICS INC(NASDAQ:PTCT) stock News

PTCT Latest News, Press Relases and Analysis

All

Press Releases

10 hours ago - By: Chartmill

PTC THERAPEUTICS INC (NASDAQ:PTCT) Presents a Compelling Case for Affordable Growth Investing

2 days ago - By: Chartmill

PTC THERAPEUTICS INC (NASDAQ:PTCT) Combines Strong Growth with Bullish Technical Setup

a day ago - By: PTC Therapeutics, Inc.

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 days ago - By: Benzinga - Mentions: BMRN ASND

PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment

a month ago - By: The Motley Fool

Here's Why Shares in PTC Therapeutics Soared This Week

a month ago - By: Yahoo Finance - Mentions: NVS PTC

PTC Therapeutics, Inc. (PTCT) Faces FDA Setback on Vatiquinone for Friedreich’s Ataxia

a month ago - By: Benzinga

PTC Therapeutics Stock Is Stuck In A Multi-Year Slump

a month ago - By: PTC Therapeutics, Inc.

PTC Therapeutics to Participate at Upcoming Investor Conferences

a month ago - By: Yahoo Finance - Mentions: RY RY.CA

PTC Therapeutics CRL ‘expected,’ focus moves to Sephience, says RBC Capital

a month ago - By: Stocktwits - Mentions: IWMW EAOR

PTC Therapeutics Stock In The Spotlight After FDA Refuses Approval For Drug To Treat Neurodegenerative Disease, Analysts Are Divided

2 months ago - By: The Motley Fool - Mentions: NVS

PTCT Earnings Beat but Sales Drop 4%

2 months ago - By: Zacks Investment Research

PTC Therapeutics (PTCT) Reports Q2 Earnings: What Key Metrics Have to Say

2 months ago - By: Zacks Investment Research - Mentions: XOMA

PTC Therapeutics (PTCT) Reports Q2 Loss, Beats Revenue Estimates

2 months ago - By: PTC Therapeutics, Inc.

PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

2 months ago - By: Stocktwits

FDA Approval Sparks Bullish Momentum In PTC Therapeutics — Here’s What Happened

2 months ago - By: PTC Therapeutics, Inc.

PTC Therapeutics Announces FDA Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

2 months ago - By: PTC Therapeutics, Inc.

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results

3 months ago - By: PTC Therapeutics, Inc.

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

3 months ago - By: PTC Therapeutics, Inc.

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

3 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

3 months ago - By: Yahoo Finance

Truist Initiates PTC Therapeutics (PTCT) Coverage with Buy Rating on Drug Launches

3 months ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

3 months ago - By: PTC Therapeutics, Inc.

PTC THERAPEUTICS INC (PTCT) Stock News

PTCT Latest News, Press Relases and Analysis